Objective To estimate the prevalence of benign prostatic hyperplasia (BPH) in the community, and study the in¯uence of BPH de®nition, age and response bias on prevalence rates. Subjects and methods A community-based longitudinal study of 3924 men aged 50±75 years was conducted in a Dutch municipality (Krimpen) near Rotterdam. Data from those responding were collected using selfadministered questionnaires, and during visits to the health centre and outpatient clinic of the urology department. The questionnaires included symptom scores on general well being (Inventory of Subjective Health, ISH) and lower urinary tract symptoms (International Prostate Symptom Score, IPSS). A short version of the questionnaire (including the IPSS and ISH) was sent to a random sample of those not responding. All subjects participating fully underwent a physical examination, uro¯owmetry, transrectal ultrasonometry of the prostate and had their prostate speci®c antigen level measured. Age-speci®c prevalence rates of BPH were estimated using different de®nitions, based on one or more of symptom severity, prostate volume and maximum¯ow rate. The in¯uence of response bias was estimated using the questionnaires. Results The response rate was 50% (full participants). Of those not responding, 55% completed a short version of the questionnaire (partial participants). Compared with full participants, partial participants had a lower IPSS and slightly lower ISH. The prevalence rates of clinical BPH in the study population was 9±20% (95% con®dence interval, 8±11% to 22±27%) depending on the de®nition used. After adjusting for nonresponse bias, the age-group speci®c prevalences for 5-year age strata were 1.1±1.8 times lower for all BPH de®nitions used. Conclusions The prevalence rates of clinical BPH depend largely on the de®nition used and increase strongly with age. The effect of age is stronger when more variables are included in the de®nition. Adjustment for response bias results in substantially lower prevalence rates.
Introduction
Clinical BPH is a common diagnosis in older men, but the reported prevalence of this condition varies considerably. Garraway et al. [1] reported a prevalence of 25% in men aged 40±79 years, whereas Bosch et al. [2] found rates of 4±19% using different de®nitions for BPH. The study of the natural history of BPH has been hampered by three major problems. First, there is a lack of consensus about the de®nition of BPH. Most de®nitions are based on the concept of Hald [3] , which combines LUTS, prostate volume and objective proof of dif®cult micturition. To describe these properties various studies have used different variables and different threshold values of these variables. Second, as most community studies have not considered nonresponse bias, it is not known whether they are truly representative. One preliminary study on potential nonresponse bias, the Olmsted County Study (OCS), suggested that the response might have been affected by concern about urological disease [4] . Third, there is a paucity of data on the natural history of BPH based on longitudinal community studies.
To gain information on male urogenital tract dysfunction, and the prevalence and incidence of clinical BPH (and its determinants) in men aged over 50 years, a prospective community-based study was designed, i.e. the Krimpen study of male urogenital tract problems and general health status. The aim of this study was to investigate the prevalence rates of BPH in the community using various de®nitions, and to study the in¯uence of age and nonresponse bias on these values.
Subjects and methods
From all general practices in Krimpen aan den IJssel (a commuter suburb near Rotterdam, with < 28 000 inhabitants) the names and addresses of all 3924 registered men aged 50±75 years were obtained (reference date June 1995). In the Netherlands, almost every person is registered with a general practice [5] . Recruitment took place between August 1995 and January 1998; the reasons for exclusion are given in Table 1 . Men previously operated for BPH (n=64) were not excluded but were analysed separately. In all cases the GP decided whether or not the patient could enter the ®rst phase of the study; the GPs' reasons for exclusion were checked by the investigators in the electronic medical records. Figure 1 presents an overview of the study scheme. All 3398 enrolled men were invited by mail to complete a self-administered questionnaire and to attend the health centre. During the recruitment period about 40 men were invited weekly. Because the recruitment period was lengthy, 152 men had passed the age of 75 years but were nevertheless enrolled; in all, 1688 men agreed to participate (a response rate of 50%).
Procedures
The questionnaire included: two inventories on general well-being, i.e. the Sickness Impact Pro®le [6, 7] and a 13-item version of the Inventory of Subjective Health (ISH) [8] ; the IPSS [9] ; the BPH impact score [10] ; and ICSsex questionnaire [11] . In addition, information on marital status, educational level, treatment for chronic diseases, smoking and drinking habits was collected.
At the health centre, two study physicians checked the questionnaires and completed these with data on the present use of medication using the Anatomical Therapeutical Chemical classi®cation [12] . Urine was analysed using a dipstick test, mainly to exclude lower urinary tract infection, and the subjects' blood pressure, height and body weight measured.
The second part of the study was conducted at the urology outpatient department of the University Hospital Rotterdam. Before attendance, participants were asked to complete a 3-day voiding diary. The following measurements were obtained: DRE; TRUS performed with a 7-MHz multiplanar sector-scanning probe to measure volumes, using the planimetric technique of volume measurement [13] ; uro¯owmetry, recording of peak¯ow rate (Q max ) and other variables with a¯owmeter (Dantec Urodyn 1000, Copenhagen, Denmark); postvoid residual urine volume, determined by transabdominal ultrasonometry; and the serum PSA level (Tandem-R method, Hybritech, San Diego, CA).
The following protocol was used to detect prostatic carcinoma. Prostate biopsies were taken; (i) from all men with PSA values of >10 ng/mL; (ii) from men with a PSA level of 2±10 ng/mL if there were abnormal ®ndings on DRE or TRUS (i.e. suspect for carcinoma); and (iii), in men with a PSA level of 1±2 ng/mL only if the DRE was abnormal. No biopsies were taken to con®rm the histopathological diagnosis of BPH. In all, 57 men had prostatic cancer and they were analysed separately; eight of these had been operated previously for BPH.
Partial participants and complete nonresponders
A random sample (500), strati®ed proportional to the number of nonresponders per general practice, was taken from the list of nonresponders to evaluate whether the responders were representative. These nonresponders were invited to complete a short mailed questionnaire which included the ISH, IPSS, and questions on treatment for chronic diseases, marital status, educational level, smoking and drinking habits, and current use of medication. Questionnaires were sent in October 1997 and had to be returned within 6 weeks. Of those not responding, 261 returned the questionnaires (response rate 55%) and became`partial participants'.
All men who completed the second part of the study and who were not diagnosed with prostatic cancer and had no previous operation for BPH (n=1553) will be re-evaluated after 2 and 4 years. 
Prevalence of BPH and estimation of response bias
The age-speci®c prevalence of BPH was estimated using different de®nitions, i.e. the de®nition used by Garraway et al. [1] and three different de®nitions reported to be the most valid by Bosch et al. [2] . The variables used in these de®nitions were the IPSS, Q max and prostate volume.
To adjust for response bias, age-group speci®c prevalences of men with an IPSS of >7 were estimated as the weighted average of the prevalence in the fullparticipant group and the estimated prevalence in the nonresponder group. It was assumed that the IPSS of the partial participants represented the IPSS of all nonresponders, and that the other variables used in the de®nitions of BPH are independent of the IPSS and equally distributed among full and partial participants.
If the total nonresponders had either lower or higher prevalences than the partial participants (in contrast to the assumption) the adjusted prevalences in those with an IPSS of >7 in the population would differ. A sensitivity analysis was conducted to evaluate the effect of variation in the IPSS in the total nonresponder group, ranging from a best-case to a worst-case scenario, on the adjusted prevalence rates of men with an IPSS of >7 in the total population.
Statistical analysis
Full and partial participants were compared for items on the short questionnaire using multivariate logistic regression, the t-test, chi-square test and the Mantel± Haenszel test, as applicable. The relation between age and prevalence rates of BPH and its determinants was tested using univariate regression (because of assumptions of normality, dependent variables were transformed), chi-square test and the Mantel±Haenszel test.
Inhabitants of Krimpen aan den IJssel n = ± 28 000
Men aged 50 to 75 years n = 3924
Moved/deceased on moment of invitation n = 291
Excluded n = 235
Responders n = 1688
Non-responders n = 1710
No information in phase I n = 27
Completed phase I* n = 1661
Random sample n = 500
Moved/deceased n = 28
Partial participants (return of questionnaire) n = 261
No return of questionnaire n = 211
Withdrawn n = 22
Phase II † n = 1666 ‡ Men with carcinoma of prostate or previous prostate operation for BPH (n = 113) men in follow-up study (n = 1553) Fig. 1 . Flow chart of the study: *self-administered questionnaire; {see text Ð 1592 men completed phase II, 69 men visited the clinic without a completed voiding diary and ®ve men completed the diary but did not visit the clinic. 
Results
Age groups of responders and nonresponders, and agegroup speci®c response rates, are given in Table 2 . There was a slight under-representation of men aged 50± 55 years and of men aged >70 years, and a slight overrepresentation of those aged 60±65 years. The mean age of the partial participants did not differ from that of the total nonresponders (62.7 years, SD 7.4 years, compared with 62.3 years, SD 7.6 years; P=0.6). Age-group speci®c response rates in the random sample are also given in Table 2 . Table 3 shows the characteristics of the included men; full participants were slightly younger than the partial participants.
Multivariate logistic regression, adjusted for age, shows that full participants had less treatment for chronic diseases (odds ratio, OR, 0.60, P<0.001), [395]
[362]
[288]
[155] marginally higher mini-ISH scores (OR 1.08, P=0.06), and a higher percentage had an IPSS of >7 (OR 1.70, P<0.02). The effect of IPSS quality of life (QoL) question in the multivariate logistic regression was similar to the effect of an IPSS of >7 when separately included in the model. When both IPSS and QoL were included in the model, the effect of these variables was much weaker, because of their strong correlation (Pearson's correlation coef®cient = 0.68, P<0.001). Prevalence rates of BPH according to different de®ni-tions and with adjustment for response bias are also given in Table 4 . Different de®nitions of BPH resulted in substantially different prevalence rates. De®nitions taking all three variables (IPSS, prostate volume and Q max ) into consideration showed a larger effect of age on the prevalence than de®nitions including only one or two variables. All (corrected and uncorrected) prevalence rates showed a signi®cant increase with age. In three of the ®ve de®nitions there was a small decrease in prevalence in those aged 70±78 years after adjusting for response bias. Adjusting for response bias resulted in lower prevalence rates for all de®nitions and across all age groups. In estimating the adjusted prevalences of those with an IPSS of >7, it was assumed that the partial participants represented the nonresponder group. The effect of the sensitivity analysis on the adjusted prevalence rates in men with an IPSS of >7 is also given in Table 4 .
Prevalence of BPH

Discussion
Considering the effort required from the responders and the number of invasive tests performed, the present 50% response rate was remarkably high. It was higher than that of two other Dutch studies on the prevalence of BPH; Bosch et al. [14] reported an age-group speci®c response rate of 33±36% and Wolfs et al. [15] reported a 39% overall response rate. In Scotland, Garraway et al. [1] reported an overall response rate of 65%, whereas the OCS reported 48% [16] . In the OCS, home visits were made to complete the questionnaire and uro¯owmetry; only a quarter of the responding men (randomly sampled) was invited for further evaluation at a urology clinic [16] . Garraway et al. [1] performed TRUS only in men with signs and symptoms of prostatic dysfunction (symptom scores and Q max ).
In the present study, all the objective measures were obtained in all full participants, allowing an estimate of community-based age-speci®c reference values for prostate size, uro¯owmetry and PSA level. Furthermore, the prevalence of BPH can then be estimated using different de®nitions. In this community-based study the prevalence rates of BPH were 9±25% in men aged 50±78 years. These rates may be an underestimate because men previously operated for BPH were not included in the calculation; however, this latter group represents only < 4% of the responders.
The full participants were comparable with the partial participants for educational and marital status, smoking and drinking habits. Full participants were slightly younger and had been treated less often treated for one or more chronic diseases, but had higher ISH scores. Partial participants were more often`delighted to mostly satis®ed' about their current voiding symptoms. Although different methods were used to evaluate nonresponse in the OCS, the present results were comparable with those in the OCS [4] ; however, prevalence rates of BPH from the OCS were not adjusted for this bias.
In the present study, the GP decided whether to propose a patient for enrolment; this may be considered as a potential limitation to the study. In retrospect, that almost 15% of the excluded men had died within one month to 2 years after exclusion suggests that the GPs' decision on eligibility was valid.
The prevalence of men with an IPSS of >7 was lower in those not responding. When estimating the prevalence rates of BPH using the IPSS as part of the de®nition it is important to adjust for this bias. In the present study, this adjustment resulted in substantially lower prevalence rates, particularly in the youngest and oldest strata. The adjusted prevalence rates of IPSS >7 would be overestimated if the partial participants had a higher IPSS than the total nonresponders. However, this overestimate is not large (3.7%) even assuming that none of the total nonresponders had an IPSS of >7. In the OCS study [4] , the total nonresponders had lower prevalence rates for BPH and other urological diagnoses than had partial responders. Therefore, the worst case scenario presented here is unlikely. It seems to be more realistic to assume that the true prevalence of men with an IPSS of >7 will be 16±20%.
In conclusion, the prevalence of BPH depends largely on age and the de®nition used. The age effect is stronger when more variables are included in the de®nition of BPH. Future prevalence studies and models using prevalence rates of BPH should use various de®nitions,
